您的购物车当前为空
别名 DRX065, DRX 065, deuterated R-enantiomer of pioglitazone
DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) without the undesired PPARγ-related weight gain side effect.


为众多的药物研发团队赋能,
让新药发现更简单!
DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) without the undesired PPARγ-related weight gain side effect.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 4,880 | 10-14周 | |
| 5 mg | ¥ 9,870 | 10-14周 | |
| 10 mg | ¥ 13,900 | 10-14周 | |
| 25 mg | ¥ 19,800 | 10-14周 | |
| 50 mg | ¥ 27,900 | 10-14周 | |
| 100 mg | ¥ 37,600 | 10-14周 |
DRX-065 相关产品
| 产品描述 | DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) without the undesired PPARγ-related weight gain side effect. |
| 别名 | DRX065, DRX 065, deuterated R-enantiomer of pioglitazone |
| 分子量 | 357.45 |
| 分子式 | C19H20N2O3S |
| CAS No. | 1259828-75-5 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容